Cite

HARVARD Citation

    Seyfrid, M. et al. (2022). CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. Journal for immunotherapy of cancer. 10 (1), p. . [Online]. 
  
Back to record